Overview

Effectiveness of Orally Dosed Emergency Contraception in Obese Women - LNG

Status:
Active, not recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
Obese women are significantly more likely than their normal BMI counterparts to experience failure of orally-dosed emergency contraceptives. The PI's preliminary data provides evidence for testing a dose escalation strategy in an effort to provide improved efficacy from orally-dosed emergency contraceptives in obese women. The overall project will be focused on both levonorgestrel (LNG) - and ulipristal acetate-containing emergency contraception but this protocol registration is for the LNG aspect of the study procedures.
Phase:
Phase 4
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
National Institutes of Health (NIH)
Treatments:
Levonorgestrel